International Pancreatic Surgery Outcomes Study - PancreasGroup.Org

PancreasGroup.Org - International Pancreatic Surgery Outcomes Study

"Snapshot" study worldwide over 3 months in 2021. Provide a verified record of true morbidity and mortality. Identify modifiable predicting factors of outcome. Obtain PubMed citable co-authorship,

The PancreasGroup.org team is conducting a "snapshot" clinical study investigating the outcomes of pancreatic surgery worldwide. This "collaborative" model for snapshot clinical studies is a well-established approach for assessing current practice in a short period of time.

There will be 3 months of prospective enrolment and 3 months follow up within a 12-month frame. The study will provide highly valuable data on outcomes after pancreatic surgery.

The investigators are aiming at providing a verified record of true morbidity and mortality in consecutive unselected patients. This way the investigators will help identify relevant, modifiable predicting factors for outcome after pancreatic surgery.

Inclusion Criteria:

• All indications (including benign and malignant)
• Open, laparoscopic or robotic.
• Elective or emergency.
• Partial or total pancreatectomies.
• Pancreatic tumour enucleations.
• Procedures with concomitant vascular or other organ resections.
• Pancreatic duct drainage procedures (e.g. Frey, Puestow, or Beger)
• Adults 18 years of age or older.

Exclusion Criteria:

• Pancreas or islet cell transplantation.
• Transcutaneous or transgastric imaging-guided ablation (e.g. RFA) or electroporation (e.g. NanoKnife).
• Endoscopic (e.g. endoscopic retrograde cholangiopancreatography, stent or lithotripsy) procedures.
• Endoscopic transgastric and surgical necrosectomies excluded.
• Patients less than 18 years of age excluded.